NeoGenomics, Inc. (NASDAQ:NEO) Q1 2023 Earnings Call Transcript
Operator: Welcome to the NeoGenomics First Quarter 2023 Financial Results Conference Call and Webcast. At this time all participants are in listen only mode.
Neogenomics Inc (NEO)
Market is closed
Sector: Services-Testing Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Greenhouse Funds Joe Milano | 2,930,014 | $51,011,544 | +5% | 4.27% |
| 2. | 48,678,000 | $36,021,720 | 1.18% | ||
| 3. | 33,000,000 | $30,958,125 | -24% | 1.02% | |
| 4. | Citadel Investment Group Ken Griffin | 1,418,105 | $24,689,208 | +139% | 0% |
| 5. | D E Shaw D. E. Shaw | 823,981 | $14,345,509 | -17% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.63 | 17,000 | Officer, Director | 72,736 | 2021-12-06 | Filing | |
| $11.60 | 26,000 | Director | 103,866 | 2018-12-21 | Filing | |
| $9.19 | 20,000 | Director | 38,782 | 2017-07-27 | Filing | |
| $6.75 | 14,800 | Director | 110,547 | 2016-03-03 | Filing | |
| $6.84 | 7,207 | Director | 117,754 | 2016-03-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.29 | 3,209 | Officer | 98,516 | 2022-03-07 | Filing | |
| $35.00 | 1,846 | Officer | 11,689 | 2021-12-21 | Filing | |
| $37.13 | 25,000 | Officer | 15,473 | 2021-11-24 | Filing | |
| $36.85 | 33,334 | Officer | 11,644 | 2021-11-26 | Filing | |
| $36.84 | 33,333 | Officer | 44,978 | 2021-11-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 21,308,380 | $370,978,898 | 0.01% | |
| 2. | 13,870,557 | $241,486,397 | 0% | |
| 3. | 7,424,352 | $129,254,598 | 0.08% | |
| 4. | 6,591,204 | $114,752,868 | 0.19% | |
| 5. | 4,886,170 | $85,069,096 | 0% |
News See All
NeoGenomics, Inc. (NASDAQ:NEO) Q4 2022 Earnings Call Transcript
Operator: Good morning. Welcome to the NeoGenomics Fourth Quarter and Full Year 2020 Earnings Conference Call.
NeoGenomics, Inc. (NASDAQ:NEO) Q3 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the NeoGenomics Third Quarter 2022 Earnings Call.
12 Biggest Genomics Companies In The World
In this article, we will discuss the 12 Biggest Genomics Companies In The World.
Here's How Artisan Partners Views NeoGenomics (NEO)
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.
Is it Still Worthy to Invest in NeoGenomics (NEO)?
Carillon Tower Advisers, an investment management firm, published its “Carillon Scout Small Cap Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
Artisan Partners Remains Optimistic in NeoGenomics (NEO), Here's Why
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Is NeoGenomics (NEO) A Smart Long-Term Buy?
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ third quarter 2021 investor letter – a copy of which can be downloaded here.
Artisan Partners on NeoGenomics (NEO): "We Remain Excited About the Company"
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here.
Alger Weatherbie Specialized Growth Fund: "We Believe NeoGenomics (NEO) is in the Sweet Spot"
Alger, an investment management firm, published its “Alger Weatherbie Specialized Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here. During the quarter, ...
Billionaire Hedge Funds
